New modular vaccine design combines best of existing vaccine technologies

MAPS technology may generate vaccines conferring strong immunity at reduced cost and risk

2013-07-30

(Press-News.org) Boston, Mass.—A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination. The method, pioneered by researchers at Boston Children's Hospital, permits rapid construction of new vaccines that activate mulitple arms of the immune system simultaneously against one or more pathogens, generating robust immune protection with a lower risk of adverse effects.

As reported by Fan Zhang, PhD, Ying-Jie Lu, PhD, and Richard Malley, MD, from Boston Children's Division of Infectious Disease, in the Proceedings of the National Academy of Sciences on July 29, the method could speed development of new vaccines for a range of globally serious pathogens, or infectious agents.

Broadly speaking, the vaccines available today fall into two categories: whole-cell vaccines, which rely on weakened or killed bacteria or viruses; and acellular or subunit vaccines, which include a limited number of antigens—portions of a pathogen that trigger an immune response. Both approaches have advantages and disadvantages.

"Whole-cell vaccines elicit a broad range of immune responses, often just as an infection would, but can cause side effects and are hard to standardize," said Malley. "Acellular vaccines can provide good early immunity with less risk of side effects, but the immune responses they induce wane with time."

The MAPS method may allow vaccine developers to take a middle ground, where they can link multiple protein and polysaccharide (sugar) antigens from one or more pathogens together in a modular fashion, much as one would connect Lego blocks.

The resulting complex—which resembles a scaffold of polysaccharides studded with proteins—can stimulate both antibody and T-cell responses simultaneously much like whole-cell vaccines, resulting in stronger immunity to the source pathogen(s). However, because the composition of a MAPS vaccine is well defined and based on the use of isolated antigens (as one would find with an acellular vaccine) the risk of side effects should be greatly reduced.

For instance, mice injected with a MAPS vaccine combining proteins from tuberculosis (TB) and polysaccharides from Streptococcus pneumoniae (pneumococcus) mounted vigorous antibody and T-cell responses against TB, whereas those vaccinated with TB protein antigens alone mounted only an antibody response.

Similarly, 90 percent of mice given a MAPS-based vaccine containing multiple pneumococcal polysaccharide and protein antigens were protected from a lethal pneumococcus infection, mounting strong antibody and T-cell responses against the bacteria. By contrast, 30 percent of mice vaccinated with the same antigens in an unbound state survived the same challenge.

"The MAPS technology gives you the advantages of: whole-cell vaccines while being much more deliberate about which antigens you include; doing it in a quantitative and precise way; and including a number of antigens so as to try to replicate the effectiveness of whole-cell vaccination," Malley explained. "The immunogenicity of these constructs is greater than the sum of their parts, somewhat because they are presented to the host as particles."

The system relies on the interactions of two compounds, biotin and rhizavidin, rather than covalent binding as is used in most of the current conjugate vaccines. To build a MAPS vaccine, biotin is bound to the polysaccharide(s) of choice and rhizavidin to the protein(s). The biotin and rhizavidin then bind together through an affinity interaction analogous to Velcro. The construction process is highly efficient, significantly reducing the time and cost of vaccine development and production.

While his team's initial work has focused on bacterial pathogens, Malley believes the technology could impact vaccine development for a broad range of pathogens, in particular those of importance in the developing world. "Technically, one could construct MAPS vaccines for viruses, parasites, even cancer antigens," he said. "And the modularity is such that one could include antigens from multiple pathogens into the same vaccine, allowing the development of combinatorial vaccines much more efficiently."

### The study was supported by the National Institute for Allergy and Infectious Diseases (grant R01AI067737) and the Translational Research Program at Boston Children's Hospital.

Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including seven members of the National Academy of Sciences, 13 members of the Institute of Medicine and 14 members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children's is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's, visit: http://vectorblog.org.

ELSE PRESS RELEASES FROM THIS DATE:

Capturing black hole spin could further understanding of galaxy growth

2013-07-30

Astronomers have found a new way of measuring the spin in supermassive black holes, which could lead to better understanding about how they drive the growth of galaxies. The scientists at Durham University, UK, observed a black hole - with mass 10 million times that of our Sun - at the centre of a spiral galaxy 500 million light years from Earth while it was feeding on the surrounding disc of material that fuels its growth and powers its activity. By viewing optical, ultra-violet and soft x-rays generated by heat as the black hole fed, they were able to measure how ...

Could sleeping stem cells hold key to treatment of aggressive blood cancer?

2013-07-30

Scientists studying an aggressive form of leukaemia have discovered that rather than displacing healthy stem cells in the bone marrow as previously believed, the cancer is putting them to sleep to prevent them forming new blood cells. The finding offers the potential that these stem cells could somehow be turned back on, offering a new form of treatment for the condition, called Acute Myeloid Leukaemia (AML). The work was led by scientists at Queen Mary, University of London with the support of Cancer Research UK's London Research Institute. Around 2,500* people are diagnosed ...

Pulsating star sheds light on exoplanet

2013-07-30

A team of researchers has devised a way to measure the internal properties of stars—a method that offers more accurate assessments of their orbiting planets. The research, which appears in Proceedings of the National Academy of Sciences, was conducted by a multi-national team of scientists, including physicists at New York University, Princeton University, and the Max Planck Institute for Solar System Research. The researchers examined HD 52265—a star approximately 92 light years away and nearly 20 percent more massive than our Sun. More than a decade ago, scientists ...

Essential clue to Huntington's disease solution found by McMaster researchers

2013-07-30

Hamilton, ON -- Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD). HD is a brain disease that can affect 1 in about 7,000 people in mid-life, causing an increasing loss of brain cells at the centre of the brain. HD researchers have known what the exact DNA change is that causes Huntington's disease since 1993, but what is typically seen in patients does not lead to disease in animal models. This has made drug discovery difficult. In this week's issue of the science journal, the Proceedings of ...

Monogamy evolved as a mating strategy

2013-07-30

Social monogamy, where one breeding female and one breeding male are closely associated with each other over several breeding seasons, appears to have evolved as a mating strategy, new research reveals. It was previously suspected that social monogamy resulted from a need for extra parental care by the father. The comparative study, by University of Cambridge researchers Dieter Lukas and Tim Clutton-Brock, shows that the ancestral system for all mammalian groups is of females living in separate ranges with males defending overlapping territories, and that monogamy evolved ...

Are you hiring the wrong person?

2013-07-30

UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS –Have you ever applied for a job and wondered why it is offered to someone who appears to be less qualified than you? A new study by Berkeley-Haas Associate Professor Don Moore finds employment managers tend to ignore the context of past performance. The article, "Attribution Errors in Performance Evaluation," (PLOS ONE, July 24, 2013), is co-authored by Samuel A. Swift, a Berkeley-Haas post-doctoral fellow; Zachariah S. Sharek, director of strategy and innovation at CivicScience; and Francesco Gino, associate ...

EARTH: A journey through Cuba's culture and geology

2013-07-30

Alexandria, VA – Few destinations capture the imagination like Cuba; a forbidden fruit to U.S. citizens since the 1960s. Recently, 14 earth scientists from the U.S.-based Association for Women Geoscientists travelled there to explore its geology and culture. The expedition is chronicled in the August issue of EARTH Magazine. While Cuba is an intriguing destination as an actor on the global political stage, its geological history captures events that tell scientists even more about the history of the planet. While there, the scientists studied rocks that captured the ...

Major changes urged for cancer screening and treatment

2013-07-30

To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.” The “Viewpoint” article will be published online Monday, July 29, in the Journal of the American Medical Association. When cancer screening programs were widely initiated three decades ago, medical knowledge of the disease was more simplistic. The intent was ...

UK's 'super mouse' yielding major discoveries in cancer research

2013-07-30

LEXINGTON, Ky. (July 26, 2013) — It appears tiny and inconsequential enough, but the "super mouse" — created by researchers at the University of Kentucky Markey Cancer Center some six years ago — has spawned plenty of new research into preventing and/or treating many types of cancer. Back in 2007, cancer researcher Vivek Rangnekar and his team announced that they discovered a gene — known as Par-4 —that specifically kills cancer cells without killing normal cells. Rangnekar's team used this gene to develop cancer-resistant mice that become known as "super mice" for ...

Make it yourself and save -- a lot

2013-07-30

It may seem like a stretch to envision a 3D printer in every home. However, a Michigan Technological University researcher is predicting that personal manufacturing, like personal computing before it, is about to enter the mainstream in a big way. "For the average American consumer, 3D printing is ready for showtime," said Associate Professor Joshua Pearce. 3D printers deposit multiple layers of plastic or other materials to make almost anything, from toys to tools to kitchen gadgets. Free designs that direct the printers are available by the tens of thousands on websites ...

New modular vaccine design combines best of existing vaccine technologies

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: